{"id":232,"date":"2014-07-29T15:13:25","date_gmt":"2014-07-29T15:13:25","guid":{"rendered":"http:\/\/nephceurope.net\/nc\/?page_id=232"},"modified":"2025-08-13T08:24:12","modified_gmt":"2025-08-13T08:24:12","slug":"factsheet-stichting-nephceurope","status":"publish","type":"page","link":"https:\/\/nephceurope.eu\/nc\/factsheet-stichting-nephceurope\/","title":{"rendered":"Factsheet  Stichting NephcEurope"},"content":{"rendered":"<p><strong>Stichting NephcEurope<\/strong><\/p>\n<p>Emailaddress:\u00a0mvm151969@gmail.com<\/p>\n<p>Belasting RSIN\/Tax code: NL 821750082B01<br \/>\nAnbi: Dossiernumber 75884 dated 10 november 2010<br \/>\nKvK number: 27365421<\/p>\n<p>Kamer van Koophandel Den Haag<br \/>\nRegistry number 27365421<\/p>\n<p>NephcEurope is an patient driven foundation for care and cure for the rare disease called Nephrotic Syndrome.<\/p>\n<p><strong>Remuneration policy\/Beloningsbeleid<\/strong><br \/>\nNephcEurope has no paid staff, but only works with volunteers. Declarations of travel expenses in case predefined approval by the official board members are the only payments made. All other income generated from donations is either spent on patient activities or research projects. The Foundation only calls for donations in case cash flow for pending projects will be too low. At this moment this is not the case.<\/p>\n<p>For an extensive overview please have a look at our balance sheets as published in the link below.<\/p>\n<p><strong>Overview of Board members and advisors to the Board\/Namen van bestuurders<br \/>\n<\/strong><strong>Official Board members Chamber of Commerce\/Offici\u00eble bestuurders bij Kamer van Koophandel:<\/strong><br \/>\nChair \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 Marieke van Meel<br \/>\nSecretary\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Bart Hoogervorst<br \/>\nIn order to saveguard the objective evaluation of income, spendings and administration an external independant Adminstration Company establishes the profit and loss reporting and the balance sheets which are published on the website.<\/p>\n<p><strong>General board members &amp; Advisors<\/strong><br \/>\nProf. Dr Jean Claude Davin<br \/>\nProf. Dr. Burkhard Toenshoff<br \/>\nMrs. Wendy Cook<br \/>\nProf. Moin Saleem<br \/>\nProf. Dr. Rishi Kafle<\/p>\n<p><strong>International liaisons<br \/>\n<\/strong>Mr Kaloian Petrov (Bulgaria)<br \/>\nMr Helder Leong (Portugal)<br \/>\nMr Tom Aelterman (NephcEurope Belgium)<br \/>\nMr Siobahn Brennan (Ireland)<br \/>\nMrs Chantal Baccalado de Lara (AESNI Spain)<br \/>\nMr Andrea Pizzo (ASNIT Italy)<\/p>\n<p><strong>Most recent update on activities in 2024 and 2025<\/strong><\/p>\n<p>In 2024 the chair of the organisation was involved in a car accident and has not been able to continue the ambitions of that year and the first half year of 2025. The networks were informed and the chairs of the cooperative parties in the various countries stepped up to visit congresses etc.<br \/>\nThe organization has been in close contact with the international contact points of ongoing developments in research, clinical trials and medication development. In general there are developments but nothing yet which really makes the change. There was no request from European Medicine Agency to get engaged in an advisory board. Nephceurope is continuing the financial support for the website of the National Dutch academic expert network. For more information visitinetworkhttps:\/\/nefrotischsyndroom-expertise.net<\/p>\n<p>The work for Nepal continues in slow pace. The focus of the activities has been on public affairs to the benefit of health care of patients with a Nephrotic Syndrome.<\/p>\n<p><strong>Activities since 2010\/Overzicht activiteiten sinds 2010<\/strong><\/p>\n<p><span style=\"text-decoration: underline;\"><strong>Organisation of international events:<\/strong><\/span><\/p>\n<ul>\n<li>3 Belgian-Dutch family days in Technopolis (Belgium), Evertshuis \u00a0(Bodegraven, Netherlands) and Plopsaland (Hasselt, Belgium)<\/li>\n<li>Organizer of first European Strategic Nephrotic Syndrome meeting in Paris, November 16<sup>th<\/sup>\u00a02013<\/li>\n<li>Organising European National Team meeting 2014, Brussels<\/li>\n<li>Co-coordination of multistakeholder event on care for kidney disease in Kathmandu 2018<\/li>\n<li>Contribution of speakers for the 2nd International Congress on organdonation and transplantation in Nepal 12th November 2022<\/li>\n<\/ul>\n<p><strong><span style=\"text-decoration: underline;\">Participation in projects:<\/span><\/strong><\/p>\n<p>Advisory role and hosting in The VSOP project Expert Network Nephrotic Syndrom <a href=\"https:\/\/nefrotischsyndroom-expertise.net\/\">the\u00a0https:\/\/nefrotischsyndroom-expertise.net\/<\/a><\/p>\n<p>Advisory role in the VSOP project Standard of Care for and GP manual on Idiopathic Nephrotic Syndrome.<\/p>\n<p><span style=\"text-decoration: underline;\"><strong>Participation in monthly international umbrella group meetings of<\/strong><\/span><\/p>\n<p>Eurordis, FEDERG, EFGCP-CMWP.<\/p>\n<p><span style=\"text-decoration: underline;\"><strong>NephcEurope donations<\/strong><\/span><\/p>\n<p>Euro 5000,&#8211; to Dr. Rutger Maas of Radboud University Medical Center for research on the re ocurrence of FSGS after transplantation<br \/>\nEuro 17500,&#8211; to professor Elena Levtchenko UZ Leuven for research on the podocyte invitro reaction to levamisole<br \/>\nEuro 300,&#8211; to host the Website\u00a0<a href=\"https:\/\/nefrotischsyndroom-expertise.net\/\">https:\/\/nefrotischsyndroom-expertise.net\/<\/a>\u00a0for the Dutch National expert network of NS.<\/p>\n<p><span style=\"text-decoration: underline;\"><strong>NephcEurope advisoryships<\/strong><\/span><\/p>\n<ul>\n<li>Patient representative in Nationale Nederlandse Academische Werkgroep Idiopathic Nefrotisch Syndroom (2000-pending)<\/li>\n<li>Scientific Advisoryship in the SAB of EurenOmics (2012-2017)<\/li>\n<li>Ethical Advisoryship in RD Connect (2012-2017), European Project for rare diseases<\/li>\n<li>Patient Advisoryship in EuroStAM, EU project on development of care for highly immunised kidney transplant patients (2012-2015)<\/li>\n<li>Member of the Registry group of RD-Connect (2016-2020)<\/li>\n<li>Member of EFGCP-CMWP (2015-2019), active participation in monthly telco meetings and organised congresses on improvement of pediatric medicine development platform<br \/>\nfor more information see\u00a0https:\/\/efgcp.eu\/cgi?lg=en&amp;pag=3844&amp;tab=400&amp;rec=5&amp;frm=0<\/li>\n<li>Member of the Biobank Assessment group of RD-Connect (2016-2019)<\/li>\n<li>Advisor for European Medicines Agency\u00a0 (upon need as called for by EMA)<\/li>\n<li>Advisor for M4 platform Germany on personalised medicine (2016-2018)<\/li>\n<li>EPAG coordinator for ERKNET (www.erknet.org), co\u00f6rdinator for the dissementation and collection of feedback from international Patient Organisation on the field of Nephrotic Syndrom. ERKNET is a EU initiative to come to an international reference network for are Kidney diseases.<br \/>\nPlease see\u00a0https:\/\/www.erknet.org\/index.php?id=280<\/li>\n<li>International patient counseling and coaching (2000-pending)<\/li>\n<li>European advisor to the Nepalese Society of Organ Donation and Transplantation (2022-)<\/li>\n<\/ul>\n<p><span style=\"text-decoration: underline;\"><strong>Publications<\/strong><\/span><\/p>\n<ul>\n<li>Contributor to Dutch Standard of Health Care for Nephrotic Syndrome<\/li>\n<li>Co writer of Nederlandse Huisartsenfolder Nefrotisch Syndroom together with NHG, NVN.<\/li>\n<li>Various other publications on registry development and transplantation<\/li>\n<\/ul>\n<p><span style=\"text-decoration: underline;\"><strong>Graduate coaching<\/strong><\/span><\/p>\n<ul>\n<li>Maaike van Ruessen, Erasmus Business School of Economics, Rotterdam The Netherlands<br \/>\n\u201cUnite the fight: medicine development for rare diseases\u201d<\/li>\n<li>Pantavos Athanasios, Undergraduate student of T.E.I of Crete, department of Human Nutrition and Dietetics, Greece<br \/>\n\u201cThe connection of food histamine to the nephrotic syndrome in children and gluten intolerance to the nephrotic syndrome in children. Comparison of Dutch and Greek guidelines\u201d<\/li>\n<\/ul>\n<p><span style=\"text-decoration: underline;\"><strong>Contribution to international Health Care Congresses<\/strong><\/span><\/p>\n<p><strong>Speaker at:<\/strong><\/p>\n<ul>\n<li>\u00a0European Society for Pediatric Nephrology 2012 in Krakow, Poland<\/li>\n<li>\u00a0Eurordis\u00a0 congress Amsterdam, The Netherlands<\/li>\n<li>\u00a0Chairmanship at the Congress of Pediatric medecines development, Brussels 2018<\/li>\n<li>\u00a0EFGCP Webinar on extrapolation of data to the benefit of medication development for Children, 2019<\/li>\n<li>\u00a0International Nepal congres dated 2019, Bodegraven, The Netherlands<\/li>\n<li>\u00a0First National Congres on Organdonation and Transplantation of Nepal, 2023<\/li>\n<\/ul>\n<p><strong>Invited Attendance:<\/strong><br \/>\nEPF Cross Border Healthcare Conference, 2013<br \/>\nRD-Connect international stakeholder conference, Brussels 2013<br \/>\nSecond international congres on Organ Donation and transplantation, Nepal 2022<br \/>\nFirst National Congres on Organdonation and Transplantation of Nepal, 2023<\/p>\n<p><strong>Balance sheet and Profit and loss account for 2023:<\/strong><\/p>\n<p><a href=\"http:\/\/nephceurope.eu\/nc\/wp-content\/uploads\/2025\/08\/Balans-winst-en-verliesrek-2024-engels.pdf\">Balans + winst en verliesrek 2024 engels<\/a><\/p>\n<p>Facebook page:\u00a0<a href=\"https:\/\/www.facebook.com\/nephceurope\/\">https:\/\/www.facebook.com\/nephceurope\/<\/a><\/p>\n<p><a href=\"http:\/\/nephceurope.eu\/nc\/wp-content\/uploads\/2021\/02\/NephcEurope-Strategic-framework-2021-2025.pdf\">NephcEurope Strategical framework 2021-2025<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Stichting NephcEurope Emailaddress:\u00a0mvm151969@gmail.com Belasting RSIN\/Tax code: NL 821750082B01 Anbi: Dossiernumber 75884 dated 10 november 2010 KvK number: 27365421 Kamer van Koophandel Den Haag Registry number 27365421 NephcEurope is an patient driven foundation for care and cure for the rare disease called Nephrotic Syndrome. Remuneration policy\/Beloningsbeleid NephcEurope has no paid staff, but only works with volunteers. [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-232","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/nephceurope.eu\/nc\/wp-json\/wp\/v2\/pages\/232"}],"collection":[{"href":"https:\/\/nephceurope.eu\/nc\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/nephceurope.eu\/nc\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/nephceurope.eu\/nc\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nephceurope.eu\/nc\/wp-json\/wp\/v2\/comments?post=232"}],"version-history":[{"count":59,"href":"https:\/\/nephceurope.eu\/nc\/wp-json\/wp\/v2\/pages\/232\/revisions"}],"predecessor-version":[{"id":738,"href":"https:\/\/nephceurope.eu\/nc\/wp-json\/wp\/v2\/pages\/232\/revisions\/738"}],"wp:attachment":[{"href":"https:\/\/nephceurope.eu\/nc\/wp-json\/wp\/v2\/media?parent=232"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}